UPDATE 1-Biodel's insulin drug found effective in mid-stage trial

... to treat type 2 diabetes patients with severe insulin resistance, who need greater than 200 units of insulin daily. Danbury, Connecticut-based Biodel's shares closed at $1.91 on the Nasdaq on Friday. (Reporting by Natalie Grover in Bangalore; ...



via Danbury Newswire http://ift.tt/1oCwIoy